Edition:
United States

Celldex Therapeutics Inc (CLDX.OQ)

CLDX.OQ on NASDAQ Stock Exchange Global Select Market

2.97USD
11 Dec 2017
Change (% chg)

-- (--)
Prev Close
$2.97
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
256,144
52-wk High
$4.07
52-wk Low
$2.20

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Sep '17 3.92 -0.203
Jun '17 3.83 -0.228
Mar '17 1.53 -0.279
FY 2016 Dec '16 1.87 -0.299
Sep '16 2.22 -0.294
Jun '16 1.39 -0.323
Mar '16 1.30 -0.351
FY 2015 Dec '15 1.79 -0.331
Sep '15 1.03 -0.324
Jun '15 2.18 -0.329
Mar '15 0.49 -0.326
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-17 5 1.61 2.11 1.00 33.86
Quarter Ending Mar-18 1 1.50 1.50 1.50 --
Year Ending Dec-17 7 10.55 11.40 9.30 14.65
Year Ending Dec-18 7 16.86 56.00 0.00 24.00
Earnings (per share)
Quarter Ending Dec-17 7 -0.25 -0.19 -0.34 -0.03
Quarter Ending Mar-18 1 -0.22 -0.22 -0.22 --
Year Ending Dec-17 7 -0.95 -0.86 -1.08 -1.14
Year Ending Dec-18 7 -0.90 -0.59 -1.09 -1.09
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 185.97 35.27
P/E High - Last 5 Yrs. -- 274.53 45.26
P/E Low - Last 5 Yrs. -- 92.51 24.18
Beta 2.70 0.83 0.91
Price to Sales (TTM) 36.19 114.29 5.83
Price to Book (MRQ) 1.79 22.17 5.62
Price to Tangible Book (MRQ) 6.69 25.97 7.22
Price to Cash Flow (TTM) -- 101.40 24.19
% Owned Institutions 54.24 5.64 1.41

Dividends

  Company industry sector
Dividend Yield -- 0.29 1.50
Dividend Yield - 5 Year Avg -- 0.26 2.04
Dividend 5 Year Growth Rate -- 1.96 5.26
Payout Ratio(TTM) -- 96.00 46.03

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 76.76 -3.18 6.84
Sales (TTM) vs TTM 1 Yr. Ago 66.49 30.07 5.66
Sales - 5 Yr. Growth Rate -6.04 33.24 10.25
EPS (MRQ) vs Qtr. 1 Yr. Ago 30.83 -149.23 7.22
EPS (TTM) vs TTM 1 Yr. Ago 22.29 -- --
EPS - 5 Yr. Growth Rate -- 43.30 10.92
Capital Spending - 5 Yr. Growth Rate 40.14 40.86 15.14

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.79 2.54
Current Ratio (MRQ) 5.91 5.74 3.56
LT Debt to Equity (MRQ) 0.00 14.43 13.40
Total Debt to Equity (MRQ) 0.00 16.88 19.46
Interest Coverage (TTM) -- -147.14 44.80

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 43.80 54.92
Gross Margin - 5 Yr. Avg. -- 55.48 52.46
EBITD Margin (TTM) -1,008.89 -- --
EBITD - 5 Yr. Avg -1,626.25 -218.62 15.49
Operating Margin (TTM) -1,172.52 -632.11 6.65
Operating Margin - 5 Yr. Avg. -1,682.68 -235.48 10.97
Pre-Tax Margin (TTM) -1,135.28 -603.10 7.47
Pre-Tax Margin - 5 Yr. Avg. -1,650.83 -235.80 11.38
Net Profit Margin (TTM) -1,088.68 -600.62 3.70
Net Profit Margin - 5 Yr. Avg. -1,650.83 -239.05 7.67
Effective Tax Rate (TTM) -- 15.26 24.26
Effective Tax Rate - 5 Yr. Avg. -- 18.70 24.06

Efficiency

  Company industry sector
Revenue/Employee (TTM) 54,439 21,614,065 848,695,288
Net Income/Employee (TTM) -592,668 -1,754,114 99,009,570
Receivable Turnover (TTM) 4.86 25.64 6.11
Inventory Turnover (TTM) -- 2.61 3.55
Asset Turnover (TTM) 0.04 0.42 0.96

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -42.53 -9.38 11.28
Return on Assets - 5 Yr. Avg. -39.61 0.11 12.25
Return on Investment (TTM) -46.04 -11.84 14.40
Return on Investment - 5 Yr. Avg. -43.55 3.18 16.04
Return on Equity (TTM) -55.70 -36.93 15.99
Return on Equity - 5 Yr. Avg. -47.44 5.57 17.25
  1 Year 3 Year 5 Year
Sales % 23.83 18.18 -6.04
EPS (TTM) % 3.41 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Celldex Therapeutics Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 8.39 5.33 76 96
13 Week 10.41 3.27 70 71
26 Week 28.57 17.43 77 68
52 Week -20.80 -32.72 35 59
YTD -16.10 -29.39 39 47
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 54.24%
# of Holders: 181
Total Shares Held: 73,762,334
3 Mo. Net Change: -2,831,811
# New Positions: 16
# Closed Positions: 19
# Increased Positions: 72
# Reduced Positions: 57
# Net Buyers: 15
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.